Avantor, Inc. (AVTR)
14.58
-0.03
(-0.21%)
USD |
NYSE |
Aug 28, 16:00
14.58
0.00 (0.00%)
After-Hours: 20:00
Avantor Free Cash Flow : 454.70M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 454.70M |
| March 31, 2026 | 438.90M |
| December 31, 2025 | 495.00M |
| September 30, 2025 | 523.60M |
| June 30, 2025 | 555.90M |
| March 31, 2025 | 666.40M |
| December 31, 2024 | 692.00M |
| September 30, 2024 | 747.20M |
| June 30, 2024 | 736.20M |
| March 31, 2024 | 639.00M |
| December 31, 2023 | 723.60M |
| September 30, 2023 | 694.60M |
| June 30, 2023 | 720.90M |
| March 31, 2023 | 774.00M |
| Date | Value |
|---|---|
| December 31, 2022 | 710.20M |
| September 30, 2022 | 799.20M |
| June 30, 2022 | 809.20M |
| March 31, 2022 | 858.40M |
| December 31, 2021 | 842.50M |
| September 30, 2021 | 867.30M |
| June 30, 2021 | 904.20M |
| March 31, 2021 | 739.50M |
| December 31, 2020 | 868.20M |
| September 30, 2020 | 657.30M |
| June 30, 2020 | 575.90M |
| March 31, 2020 | 480.30M |
| December 31, 2019 | 302.40M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Medpace Holdings, Inc. | 706.69M |
| Champions Oncology, Inc. | -5.036M |
| Personalis, Inc. | -100.98M |
| Adaptive Biotechnologies Corp. | -24.03M |
| 10X Genomics, Inc. | 121.44M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 178.20M |
| Cash from Investing (Quarterly) | -37.30M |
| Cash from Financing (Quarterly) | -112.40M |
| Free Cash Flow Per Share (Quarterly) | 0.2076 |
| Free Cash Flow to Equity (Quarterly) | 259.10M |
| Free Cash Flow to Firm (Quarterly) | 164.72M |
| Free Cash Flow Yield | 4.59% |